Business
Why the Dimerix (ASX:DXB) share price is surging 6% higher today
The Dimerix Ltd (ASX: DXB) share price lifted higher today after the company announced the start of its second clinical study on lead drug candidate, DMX-200. At the time of writing, the Dimerix share price is up 6.1% at 26 cents.
What’s driving the Dimerix share price?
The Dimerix share price is storming higher following the announcement of its international study into COVID-19 patients. Led by Professor Meg Jardine at the University of Sydney Australia, the clinical trial will collaborate with Professor Vivek Jha and The George Institute for Global Health, in India.
DMX-200 was chosen for a partner study of the controlled evaluation of angiotensin receptor blockers for COVID-19 respiratory disease (Clarity) study. The Clarity…
-
General13 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
Noosa News18 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General15 hours agoTrump mulling whether to fire US Fed chair Powell
-
Noosa News18 hours agoNowhere is growing like this corner of Queensland. It’s changing the political game